|
GPR89B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.055960E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.194140E-02 |
| Normal-vs-Stage2 |
8.180700E-04 |
| Normal-vs-Stage3 |
3.994100E-04 |
| Normal-vs-Stage4 |
1.031210E-04 |
| Stage1-vs-Stage2 |
8.971700E-02 |
| Stage1-vs-Stage3 |
4.212200E-02 |
| Stage1-vs-Stage4 |
9.478100E-03 |
| Stage2-vs-Stage3 |
9.760000E-01 |
| Stage2-vs-Stage4 |
4.649000E-01 |
| Stage3-vs-Stage4 |
4.126600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.586400E-04 |
| Normal-vs-AfricanAmerican |
2.376000E-02 |
| Normal-vs-Asian |
3.964400E-01 |
| Caucasian-vs-AfricanAmerican |
4.140000E-01 |
| Caucasian-vs-Asian |
6.602400E-01 |
| AfricanAmerican-vs-Asian |
9.165400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.62779999999852E-05 |
| Normal-vs-Female |
6.098100E-02 |
| Male-vs-Female |
1.575740E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74614999999267E-05 |
| Normal-vs-Age(41-60Yrs) |
1.364560E-03 |
| Normal-vs-Age(61-80Yrs) |
1.503100E-03 |
| Normal-vs-Age(81-100Yrs) |
4.772000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.325910E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.327650E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.329840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.745000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.253400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.297600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.564200E-01 |
| Normal-vs-Grade 2 |
1.254360E-02 |
| Normal-vs-Grade 3 |
1.104040E-03 |
| Normal-vs-Grade 4 |
2.92079999997252E-06 |
| Grade 1-vs-Grade 2 |
9.515400E-01 |
| Grade 1-vs-Grade 3 |
5.415200E-01 |
| Grade 1-vs-Grade 4 |
4.777700E-02 |
| Grade 2-vs-Grade 3 |
1.707420E-01 |
| Grade 2-vs-Grade 4 |
2.239600E-04 |
| Grade 3-vs-Grade 4 |
6.864800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.371700E-02 |
| Normal-vs-ccB subtype |
6.18319999999839E-05 |
| ccA subtype-vs-ccB subtype |
8.0752999999989E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.238700E-03 |
| Normal-vs-N1 |
2.13959999999513E-05 |
| N0-vs-N1 |
3.721100E-03 |
|
|
